A double blinded, randomized, comparative clinical trial to determine the efficacy of Col-Red compared with Placebo on reducing cholesterol in hypercholesterolemia patients - ColRed Clinical Trial

British Biologicals0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•A total of 30 Subjects aged between 18-65 years with known but untreated moderate hypercholesterolemia.
•Subjects diagnosed with total cholesterol equal to or above 200 mg/dl and who have LDL-cholesterol levels equal to or above 130 mg/dl
•Subjects who give their consent to participate after being informed of the study objectives

•Severe disease necessitating pharmacological intervention
•Hepatic disease, gastrointestinal complaints and ulcers, thyroid dysfunction or any kidney disease;
•Personal history of cardiovascular illness.
•Uncontrolled diabetes and uncontrolled hypertension in terms of the WHO criteria (140/90 mmHg)
•Known food allergy.
•Significant chronic organic or psychiatric disease
•Not obtaining informed consent
•Pregnant or lactating subjects.

发起方

British Biologicals